Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Barts and The London School of Medicine and Dentistry
Entity

Barts and The London School of Medicine and Dentistry

Tracked across 1 events · 108 articles · First seen Aug 19, 2026 · Last active Aug 24, 2026

Sentiment
50
Attention
7
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
7 50
Tech
Moderna Merck mRNA melanoma vaccine trial success
Moderna and Merck announced on August 19, 2026, that their personalized mRNA cancer vaccine, intismeran autogene, combined with Merck's immunotherapy drug Pembrolizumab, met its primary and key secondary endpoints in a Phase 3 trial for…
Impact: Oncologist Marco Gerlinger called the results a breakthrough and proof of principle.
Aug 19, 2026 · 108 articles
Key Actions (1)
40 Barts and The London School of Medicine and Dentistry called it breakthroughModerna Merck mRNA...
ERGEN INTELLIGENCE
Track Barts and The London School of Medicine and Dentistry live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.